- Kowa routinely monitors the safety of all its pharmaceutical products and devices. This includes review of safety data from clinical studies, and collection of reports and cases of adverse events for marketed products.
Patients and volunteers in clinical trials reporting an adverse event must contact the investigator.
- For reporting adverse events within the European Union please contact:
- E-Mail: firstname.lastname@example.org